MORGAN STANLEY - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 49 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$330,947
-26.9%
20,946
-30.0%
0.00%
Q2 2023$452,730
-25.2%
29,903
-28.4%
0.00%
Q1 2023$605,637
+80.0%
41,768
+67.8%
0.00%
Q4 2022$336,460
+102.7%
24,886
+136.3%
0.00%
Q3 2022$166,000
-35.7%
10,530
-50.3%
0.00%
Q2 2022$258,000
+230.8%
21,185
+153.4%
0.00%
Q1 2022$78,000
+9.9%
8,361
+100.9%
0.00%
Q4 2021$71,0004,1620.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$64,173,86826.74%
5AM Venture Management, LLC 4,408,379$63,921,49616.35%
72 Investment Holdings, LLC 509,023$7,380,8333.50%
StepStone Group LP 761,277$11,038,5172.05%
TCG Crossover Management, LLC 584,955$8,481,8481.65%
Redmile Group, LLC 1,831,608$26,558,3161.15%
Nan Fung Group Holdings Ltd 73,582$1,066,9390.73%
Baker Brothers Advisors 4,865,819$70,554,3760.38%
CHI Advisors LLC 56,374$817,4230.22%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,522,5000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders